LANGUAGECompany Profile
- Company name
- Riken Immune Regenerative Medicine Inc.
- Location
- 10-2 Ichiban-cho, Chiyoda-ku, Tokyo
- Tel
- +81-(0)3-5226-5880
- President and CEO
- Jie Tokuoka
Main management team
- Chairman
- Ken Matsuzawa
- President and CEO
- Jie Tokuoka
- Directors
- Koichiro Abe
Shigeo Yoshida
Yoshinari Kawai
- Auditor
- Masafumi Tachihara
History
| Year and month | Overview |
|---|---|
| October 2014 | Establishment of RIKEN NKT Technology Co., Ltd. |
| December 2014 | RIKEN Certified Venture The company’s name changed to RIKEN Immune Regenerative Medicine Inc. |
| October 2015 | Moved to Chiyoda-ku, Tokyo |
| November 2015 | RIKEN-initiated venture |
Business summary
We have developed highly safe drugs and culture methods necessary for NKT cell-targeted therapy, and in cooperation with affiliated medical institutions and joint research institutions, we are disseminating NKT cell-targeted therapy as a medical treatment not covered by insurance.We will continue to strive to expand the opportunities we provide and further promote our business based on basic science.